This study investigates pancreatic cancer. Peripheral blood samples will be used to develop a diagnostic model using cell-free DNA (cfDNA).
The purpose of this study is to evaluate a multi-omics model. This model will help distinguish pancreatic cancer from non-cancer conditions.
- Who can participate: Participants aged 18-75 years with a diagnosis of pancreatic cancer, precancerous lesions, or non-malignant pancreatic conditions can join. They must not have received any antitumor therapy and should be able to provide consent.
- Study details: Participants will provide blood samples for analysis. The study includes an investigational model to evaluate cancer signatures. A placebo is not involved in this study.